3rd International Electronic Conference on Medicinal Chemistry
the chair
Further to the success of the two first editions, Pharmaceuticals, a peer-reviewed journal edited by MDPI, is proud to organize and sponsor the 3rd International Electronic Conference on Medicinal Chemistry. Contributions dealing with any discipline promoting research in drug discovery and development will be welcome.
The conference will be held online (www.sciforum.net/conference/ecmc-3) from November 1–30, 2017. It will enable you to share your recent results with scientists of academic and industrial groups from all over the world.
Participation, as an author or a visitor, is ABSOLUTELY FREE (simply create an account on the home page). Abstracts of the presentations will be published, upon authorization of the authors, in a meeting report after the conference.
On behalf of our dynamic editorial staff and active scientific committee, we warmly invite you to join us during this third edition and we look forward to posting your contributions.
All participants of ECMC-3 are welcome to submit the extended work to the Pharmaceuticals Special Issue "Selected Papers from the 3rd International Electronic Conference on Medicinal Chemistry".
Conference Chair
|
Dr. Jean Jacques Vanden Eynde |
 |
Conference Committee
|
IPBLN-CSIC, Spain |
Universidade do Porto, Portugal |
University of Nebraska Medical Center, USA |
|
Haute Ecole Provinciale de Hainaut-Condorcet, Belgium |
Université Libre de Bruxelles, Belgium |
Universidade Federal do Rio de Janeiro, Brazil |
|
Università degli Studi di Cagliari, Italy |
Important Dates
- Abstract submission deadlineOct 15, 2017
- Abstract acceptance notificationOct 20, 2017
- Full file submission deadlineOct 25, 2017
- A. ECMC-3
- B. Posters
- C. Round Table on Nanomedicines
- D. Round Table on Parasitic Diseases
MDPI AG, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their research works. Hence, by submitting a contribution to this conference, the authors retain the copyright of their contribution, but they grant MDPI AG the non-exclusive right to publish this contribution online on the Sciforum.net platform. This means the authors can easily submit their contribution to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
This year, as a sponsor, Pharmaceuticals would like to award the best presentation as elected by all the organizers. The Award will consist of 500 Swiss Francs. We look forward to posting your contributions.
Criteria for Evaluation of Best Presentation Award 2017:
Criteria
- Full PPT presentation must be submitted to ECMC-3.
- The quality of the presentation.
- The scientific content of the presentation
Evaluation
- Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above.
- Total score for each presentation will be ranked, from highest to lowest.
- If two or more students get the same score, further evaluation will be carried out.
- All decisions made by the Evaluation Committee are final.
Best Presentation at ECMC-3
Pharmaceuticals and the Organizing Committee of ECMC-3 congratulate Jalal Soubhye who received an award for the best presentation at ECMC-3:
Topic: Dual Anti-Inflammatory and Anti-Bacterial Effects of Phenylhydrazide and Phenylhydrazone Derivatives
authored by Jalal Soubhye,
Laboratoire de Chimie Pharmaceutique Organique, Faculté de Pharmacie, Université Libre de Bruxelles, Campusplaine, CP 205/5, 1050 Brussels, Belgium.
"Currently, Dr. Jalal Soubhye works as academic researcher at the Université Libre de Bruxelles (ULB) in the field of medicinal chemistry, whose research focuses on pharmacological design, synthesis and evaluation of new chemical substances with therapeutic potential. His current research interests are in the development and evaluation (in vitro and in vivo) of myeloperoxidase inhibitors as anti-inflammatory agents. Understanding of the mechanism of inhibition is very important to obtain new potent and safe inhibitors. In addition, he is working on design, synthesis and evaluation of new antimicrobial agents."
Electronic Exhibition Hall of ECMC - Develop and Strengthen Your Brand
- Free of charge for companies exhibited in 2017.
- High visibility: The last edition of this series provided the opportunity to more than 10,000 visitors to browse
among 42 relevant slide shows and videos, presented by 150 authors from 22 countries. - Super easy to prepare: a short introduction of your company, and a PPT presentation (less than 10 slides) to show super star products.
Old pharmaceuticals with new applications: the case studies of lucanthone and mitoxantrone
Related papers Old Pharmaceuticals with New Applications: the Case Studies of Lucanthone and Mitoxantrone
Synthesis,Characterization,Molecular docking and Structure-Activity Relationships of Novel Thiazolo[3,2-α]pyrimidines as Prospective Acetylcholinesterase Inhibitors
Related papers Synthesis, Characterization, Molecular docking and Structure-Activity Relationships of Novel 2-Arylidene- and 2-Aminomethylenethiazolo[3,2-a]pyrimidines as Prospective Acetylcholinesterase Inhibitors